{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:27:14Z","timestamp":1778657234043,"version":"3.51.4"},"reference-count":59,"publisher":"BMJ","issue":"5","funder":[{"name":"Umbrella Sexual Health Services, University Hospital Birmingham NHS Foundation Trust"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"accepted":{"date-parts":[[2021,1,22]]},"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To identify economic evaluations of interventions to control STIs and HIV targeting young people, and to assess how costs and outcomes are measured in these studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Systematic review.<\/jats:p><\/jats:sec><jats:sec><jats:title>Data sources<\/jats:title><jats:p>Seven databases were searched (Medline (Ovid), EMBASE (Ovid), Web of Science, PsycINFO, NHS Economic Evaluation Database, NHS Health Technology Assessment and Database of Abstracts of Reviews of Effects) from January 1999 to April 2019. Key search terms were STIs (chlamydia, gonorrhoea, syphilis) and HIV, cost benefit, cost utility, economic evaluation, public health, screening, testing and control.<\/jats:p><\/jats:sec><jats:sec><jats:title>Review methods<\/jats:title><jats:p>Studies were included that measured costs and outcomes to inform an economic evaluation of any programme to control STIs and HIV targeting individuals predominantly below 30 years of age at risk of, or affected by, one or multiple STIs and\/or HIV in Organisation for Economic Co-operation and Development countries. Data were extracted and tabulated and included study results and characteristics of economic evaluations. Study quality was assessed using the Philips and BMJ checklists. Results were synthesised narratively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>9530 records were screened and categorised. Of these, 31 were included for data extraction and critical appraisal. The majority of studies assessed the cost-effectiveness or cost-utility of screening interventions for chlamydia from a provider perspective. The main outcome measures were major outcomes averted and quality-adjusted life years. Studies evaluated direct medical costs, for example, programme costs and 11 included indirect costs, such as productivity losses. The study designs were predominantly model-based with significant heterogeneity between the models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion\/Conclusion<\/jats:title><jats:p>None of the economic evaluations encompassed aspects of equity or context, which are highly relevant to sexual health decision-makers. The review demonstrated heterogeneity in approaches to evaluate costs and outcomes for STI\/HIV control programmes. The low quality of available studies along with the limited focus, that is, almost all studies relate to chlamydia, highlight the need for high-quality economic evaluations to inform the commissioning of sexual health services.<\/jats:p><\/jats:sec>","DOI":"10.1136\/sextrans-2020-054873","type":"journal-article","created":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T18:20:38Z","timestamp":1614709238000},"page":"334-344","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Assessing the costs and outcomes of control programmes for sexually transmitted infections: a systematic review of economic evaluations"],"prefix":"10.1136","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1779-8616","authenticated-orcid":false,"given":"Sonja C M","family":"Bloch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8492-0020","authenticated-orcid":false,"given":"Louise J","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5462-1158","authenticated-orcid":false,"given":"Emma","family":"Frew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4193-6919","authenticated-orcid":false,"given":"Jonathan D C","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,3,2]]},"reference":[{"key":"2024092104001020000_97.5.334.1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-1"},{"key":"2024092104001020000_97.5.334.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2009.07.012"},{"key":"2024092104001020000_97.5.334.3","unstructured":"National Institute for Health and Care Excellence (NICE) . Developing NICE guidelines: the manual, 2014. Available: https:\/\/www.nice.org.uk\/process\/pmg20 [Accessed 9 Nov 2020]."},{"key":"2024092104001020000_97.5.334.4","unstructured":"National Institute for Health and Care Excellence (NICE) . Methods for the development of NICE public health guidance (third edition), 2012. Available: https:\/\/www.nice.org.uk\/process\/pmg4\/chapter\/introduction [Accessed 13 May 2020]."},{"key":"2024092104001020000_97.5.334.5","unstructured":"Swedish Council on Health Technology Assessment . Methods for health economic evaluations - A guideline based on current practices in Europe, 2015."},{"key":"2024092104001020000_97.5.334.6","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.08.059212"},{"key":"2024092104001020000_97.5.334.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2013.10.005"},{"key":"2024092104001020000_97.5.334.8","doi-asserted-by":"publisher","DOI":"10.3310\/hta14220"},{"key":"2024092104001020000_97.5.334.9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/phr03130","article-title":"Sexual health promotion for young people delivered via digital media: a scoping review","volume":"3","author":"Bailey","year":"2015","journal-title":"Public Health Res"},{"key":"2024092104001020000_97.5.334.10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"key":"2024092104001020000_97.5.334.11","unstructured":"Centre for Reviews and Dissemination, University of York . Systematic Reviews: CRD\u2019s guidance for undertaking reviews in health care. Centre for Reviews and Dissemination, University of York: York, 2009."},{"key":"2024092104001020000_97.5.334.12","unstructured":"European Centre for Disease Prevention and Control . European network for STI Surveillance, 2020. Available: https:\/\/www.ecdc.europa.eu\/en\/about-uswho-we-workdisease-and-laboratory-networks\/european-network-sti-surveillance [Accessed 23 Apr 2020]."},{"key":"2024092104001020000_97.5.334.13","unstructured":"European Centre for Disease Prevention and Control . European network for HIV\/AIDS Surveillance, 2020. Available: https:\/\/www.ecdc.europa.eu\/en\/about-uswho-we-workdisease-and-laboratory-networks\/european-network-hivaids-surveillance [Accessed 23 Apr 2020]."},{"key":"2024092104001020000_97.5.334.14","unstructured":"OECD\/EU . Health at a glance: Europe 2016 -state of health in the EU cycle. Paris, 2016."},{"key":"2024092104001020000_97.5.334.15","doi-asserted-by":"publisher","DOI":"10.1177\/0141076815587658"},{"key":"2024092104001020000_97.5.334.16","unstructured":"National Institute for Health and Care Excellence (NICE) . Who we are, 2019. Available: https:\/\/www.nice.org.uk\/about\/who-we-are [Accessed 19 Mar 2019]."},{"key":"2024092104001020000_97.5.334.17","unstructured":"Clarivate Analytics . Endnote, 2019. Available: https:\/\/endnote.com\/ [Accessed 16 May 2019]."},{"key":"2024092104001020000_97.5.334.18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1471-0528.2002.00223.x","article-title":"Antenatal ultrasound screening for fetal abnormalities: a systematic review of studies of cost and cost effectiveness","volume":"109","author":"Roberts","year":"2002","journal-title":"BJOG"},{"key":"2024092104001020000_97.5.334.19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.313.7052.275"},{"key":"2024092104001020000_97.5.334.20","doi-asserted-by":"crossref","DOI":"10.3310\/hta8360","article-title":"Review of guidelines for good practice in decision-analytic modelling in health technology assessment","volume":"8","author":"Philips","year":"2004","journal-title":"Health Technol Assess"},{"key":"2024092104001020000_97.5.334.21","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2014-051677"},{"key":"2024092104001020000_97.5.334.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2007.00225.x"},{"key":"2024092104001020000_97.5.334.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2006.00075.x"},{"key":"2024092104001020000_97.5.334.24","doi-asserted-by":"publisher","DOI":"10.1258\/0956462042563765"},{"key":"2024092104001020000_97.5.334.25","doi-asserted-by":"publisher","DOI":"10.1136\/sti.77.4.276"},{"key":"2024092104001020000_97.5.334.26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s101980070003","article-title":"Cost-effectiveness of screening asymptomatic women for Chlamydia trachomatis: The importance of reinfection and partner referral","volume":"1","author":"Postma","year":"2000","journal-title":"Heal Econ Prev Care"},{"key":"2024092104001020000_97.5.334.27","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-200010000-00005"},{"key":"2024092104001020000_97.5.334.28","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2014-051715"},{"key":"2024092104001020000_97.5.334.29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c7250"},{"key":"2024092104001020000_97.5.334.30","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2006.024364"},{"key":"2024092104001020000_97.5.334.31","doi-asserted-by":"crossref","DOI":"10.3310\/hta11080","article-title":"Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection","volume":"11","author":"Low","year":"2007","journal-title":"Health Technol Assess"},{"key":"2024092104001020000_97.5.334.32","doi-asserted-by":"publisher","DOI":"10.1057\/palgrave.jors.2602134"},{"key":"2024092104001020000_97.5.334.33","doi-asserted-by":"publisher","DOI":"10.1093\/imaman\/dpi022"},{"key":"2024092104001020000_97.5.334.34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2004.00324.x"},{"key":"2024092104001020000_97.5.334.35","doi-asserted-by":"publisher","DOI":"10.2307\/253962"},{"key":"2024092104001020000_97.5.334.36","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/01.AOG.0000204187.86600.0a","article-title":"Cost-effectiveness of screening strategies for gonorrhea among females in private sector care","volume":"107","author":"Bernstein","year":"2006","journal-title":"Obstet Gynecol"},{"key":"2024092104001020000_97.5.334.37","doi-asserted-by":"publisher","DOI":"10.1097\/01.olq.0000154501.22566.fa"},{"key":"2024092104001020000_97.5.334.38","doi-asserted-by":"publisher","DOI":"10.1097\/01.olq.0000175414.80023.59"},{"key":"2024092104001020000_97.5.334.39","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jadohealth.2017.08.028","article-title":"The optimal age for screening adolescents and young adults without identified risk factors for HIV","volume":"62","author":"Neilan","year":"2018","journal-title":"J Adolesc Health"},{"key":"2024092104001020000_97.5.334.40","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e31821b0f50"},{"key":"2024092104001020000_97.5.334.41","doi-asserted-by":"publisher","DOI":"10.1097\/01.olq.0000200609.77577.3f"},{"key":"2024092104001020000_97.5.334.42","doi-asserted-by":"publisher","DOI":"10.1080\/14034940410026282"},{"key":"2024092104001020000_97.5.334.43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/B:HCMS.0000020653.31862.23","article-title":"Applying a mixed-integer program to model re-screening women who test positive for C. trachomatis infection","volume":"7","author":"Tao","year":"2004","journal-title":"Health Care Manag Sci"},{"key":"2024092104001020000_97.5.334.44","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00007435-200209000-00009","article-title":"A cost-effectiveness evaluation of testing and treatment of Chlamydia trachomatis infection among asymptomatic women infected with Neisseria gonorrhoeae","volume":"29","author":"Gift","year":"2002","journal-title":"Sex Transm Dis"},{"key":"2024092104001020000_97.5.334.45","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2011-050067"},{"key":"2024092104001020000_97.5.334.46","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.amepre.2016.01.007","article-title":"Cost-Effectiveness of Opt-Out Chlamydia testing for high-risk young women in the U.S","volume":"51","author":"Owusu-Edusei","year":"2016","journal-title":"Am J Prev Med"},{"key":"2024092104001020000_97.5.334.47","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e31818b64ac"},{"key":"2024092104001020000_97.5.334.48","doi-asserted-by":"publisher","DOI":"10.1071\/SH06016"},{"key":"2024092104001020000_97.5.334.49","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-141-7-200410050-00006"},{"key":"2024092104001020000_97.5.334.50","unstructured":"Drummond MF , Sculpher MJ , Claxton K . Methods for the economic evaluation of health care programmes. 4th edn. Oxford: Oxford University Press, 2015."},{"key":"2024092104001020000_97.5.334.51","doi-asserted-by":"crossref","unstructured":"Drummond M , Sculpher M , Torrance G . Methods for the economic evaluation of health care programmes. Oxford University Press: Oxford, 2005.","DOI":"10.1093\/oso\/9780198529446.001.0001"},{"key":"2024092104001020000_97.5.334.52","unstructured":"US Institute of Medicine . Vaccines for the 21st century: a tool for decisionmaking. In: Stratton KR , Durch JS , Lawrence RS , eds. Vaccines for the 21st century. Washington, DC: National Academy Press, 2000: 149\u201358."},{"key":"2024092104001020000_97.5.334.53","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e31815b07dd"},{"key":"2024092104001020000_97.5.334.54","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-015-1975-z","article-title":"Optimizing strategies for population-based Chlamydia infection screening among young women: an age-structured system dynamics approach","volume":"15","author":"Teng","year":"2015","journal-title":"BMC Public Health"},{"key":"2024092104001020000_97.5.334.55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00007435-200202000-00004","article-title":"Cost-effectiveness of five strategies for gonorrhea and Chlamydia control among female and male emergency department patients","volume":"29","author":"Mehta","year":"2002","journal-title":"Sex Transm Dis"},{"key":"2024092104001020000_97.5.334.56","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2005.017517"},{"key":"2024092104001020000_97.5.334.57","unstructured":"Health Information and Quality Authority . Guidelines for the economic evaluation of health technologies in Ireland 2020. Dublin, 2020. Available: https:\/\/www.hiqa.ie\/reports-and-publications\/health-technology-assessment\/guidelines-economic-evaluation-health [Accessed 15 Jan 2021]."},{"key":"2024092104001020000_97.5.334.58","unstructured":"Royal College of Physicians . Alcohol and sex: a cocktail for poor sexual health. London: RCP, 2011. https:\/\/www.rcplondon.ac.uk\/news\/nhs-missing-key-opportunities-tackle-alcohol-abuse"},{"key":"2024092104001020000_97.5.334.59","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.clindermatol.2013.08.002","article-title":"Sexual health in adolescents","volume":"32","author":"Slater","year":"2014","journal-title":"Clin Dermatol"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2020-054873","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T11:00:53Z","timestamp":1726916453000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2020-054873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,2]]},"references-count":59,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,7,19]]},"published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.1136\/sextrans-2020-054873"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2020-054873","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,2]]}}}